These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Coronary risk and dyslipidemia in type 2 diabetic patients. Udawat H; Goyal RK; Maheshwari S J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328 [TBL] [Abstract][Full Text] [Related]
23. [Disorders of lipid metabolism in type 2 diabetics]. Ivancová G; Tkácová R; Ivanco I Vnitr Lek; 1992 Aug; 38(8):759-63. PubMed ID: 1455758 [TBL] [Abstract][Full Text] [Related]
24. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
25. Dyslipidaemia in diabetic patients: time for a rethink. Shepherd J Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054 [TBL] [Abstract][Full Text] [Related]
26. Study of serum lipid profile in type 2 diabetic patients attending KMCTH. Mathura KC; Vaidya B; Gurbacharya DL Nepal Med Coll J; 2005 Dec; 7(2):97-100. PubMed ID: 16519073 [TBL] [Abstract][Full Text] [Related]
27. Dyslipidaemia and coagulation defects of insulin resistance. Frohlich J; Steiner G Int J Clin Pract Suppl; 2000 Oct; (113):14-22. PubMed ID: 11965826 [TBL] [Abstract][Full Text] [Related]
28. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention. Steinmetz A Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835 [TBL] [Abstract][Full Text] [Related]
31. Treatment of lipids and type 2 diabetes. Hermayer KL Curr Cardiol Rep; 2004 Nov; 6(6):443-50. PubMed ID: 15485606 [TBL] [Abstract][Full Text] [Related]
32. Introduction: New insight into understanding the relation of type 2 diabetes mellitus, insulin resistance, and cardiovascular disease. Hsueh WA Am J Cardiol; 2003 Aug; 92(4A):1J-2J. PubMed ID: 12957320 [No Abstract] [Full Text] [Related]
33. [Is it worthwhile treating the dyslipidemia of patients with coronary disease?]. Giannini SD Arq Bras Cardiol; 1992 Apr; 58(4):253-4. PubMed ID: 1340692 [No Abstract] [Full Text] [Related]
34. [Prevention of atherosclerotic cardiovascular disease in infantile dyslipidemias]. Pongiglione R; Rondinone R Minerva Pediatr; 1988 Nov; 40(11):625-32. PubMed ID: 3246988 [No Abstract] [Full Text] [Related]
35. Management of Lipids in Patients with Diabetes. Mbue ND; Mbue JE; Anderson JA Nurs Clin North Am; 2017 Dec; 52(4):605-619. PubMed ID: 29080581 [TBL] [Abstract][Full Text] [Related]
36. Control of blood lipids in diabetes. Pometta D; James R Diabetes Res Clin Pract; 1988; 4 Suppl 1():47-9. PubMed ID: 3402327 [No Abstract] [Full Text] [Related]
39. [Limited application of prevention measures in patients with diabetes mellitus type 2 and coronary artery disease in Spain. DIETRIC study]. Rodríguez Padial L; Maicas Bellido C; Alcalá López J; Velázquez Martín M; Gil Polo B Rev Clin Esp; 2005 Jan; 205(1):14-8. PubMed ID: 15718012 [TBL] [Abstract][Full Text] [Related]